Pharma gift ban in the crosshairs

All three gubernatorial candidates see defects in Massachusetts' gift ban, notes a State House News Service report outlining the views of Democrat Deval Patrick, Republican Charles Baker and Independent Tim Cahill.

That means the ban on pharma company gifts to doctors, passed by lawmakers in 2008, could soon either be removed in the next legislative session, as Baker and Cahill would do, or changed to parallel prevailing PhRMA guidelines, which is Patrick's preference. Critics say the ban stymies education, and restaurants have balked at the loss of revenue from pharma dinners. The ban was nearly repealed during the most recent session.
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.